Hong Kong stocks fluctuate | Lai Kai Pharmaceutical-B (02105.HK) rises over 5% Recently signed a global exclusive license agreement with Vasque Bio for LAE118

According to the Chinese financial news app, the stock of Kaixi Pharmaceuticals-B (02105.HK) rose more than 5% in the morning trading. As of the time of the report, it had increased by 4.78% to 9.42 Hong Kong dollars, with a trading volume of 14.22 million Hong Kong dollars.